Norges Bank Reata Pharmaceuticals Inc Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$0.0 - $172.36 $0 - $34.3 Million
-198,730 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$79.22 - $105.37 $11.5 Million - $15.3 Million
145,582 New
145,582 $14.8 Million
Q2 2023

Aug 14, 2023
SELL
$79.22 - $105.37 $15.7 Million - $20.9 Million
-198,730 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$30.85 - $93.17 $5.11 Million - $15.4 Million
165,482 New
165,482 $15 Million
Q4 2022

Feb 14, 2023
BUY
$22.15 - $42.11 $4.55 Million - $8.65 Million
205,319 New
205,319 $7.8 Million
Q3 2022

Nov 13, 2023
BUY
$19.41 - $36.49 $3.86 Million - $7.25 Million
198,730 New
198,730 $4.99 Million
Q2 2022

Aug 14, 2023
BUY
$20.71 - $36.5 $4.12 Million - $7.25 Million
198,730 New
198,730 $6.04 Million
Q1 2022

May 12, 2023
SELL
$24.12 - $39.6 $420,580 - $690,505
-17,437 Reduced 8.49%
187,882 $6.16 Million
Q1 2022

May 09, 2022
SELL
$24.12 - $39.6 $5.28 Million - $8.66 Million
-218,725 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$25.61 - $110.96 $5.6 Million - $24.3 Million
218,725 New
218,725 $5.77 Million
Q3 2021

Nov 14, 2022
BUY
$100.0 - $143.02 $21.9 Million - $31.3 Million
218,725 New
218,725 $22 Million
Q3 2021

Nov 05, 2021
SELL
$100.0 - $143.02 $21.3 Million - $30.5 Million
-213,497 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$78.27 - $151.29 $16.7 Million - $32.3 Million
213,497 New
213,497 $30.2 Million
Q2 2021

Aug 10, 2021
SELL
$78.27 - $151.29 $15.2 Million - $29.3 Million
-193,738 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$94.25 - $132.81 $18.3 Million - $25.7 Million
193,738 New
193,738 $19.3 Million
Q1 2021

May 07, 2021
SELL
$94.25 - $132.81 $18.9 Million - $26.7 Million
-200,774 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$102.03 - $184.62 $20.5 Million - $37.1 Million
200,774 New
200,774 $24.8 Million
Q4 2020

Feb 10, 2021
SELL
$102.03 - $184.62 $21.4 Million - $38.8 Million
-210,053 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$93.53 - $163.34 $19.6 Million - $34.3 Million
210,053 New
210,053 $20.5 Million
Q3 2020

Nov 10, 2020
SELL
$93.53 - $163.34 $22.3 Million - $38.9 Million
-237,912 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$126.3 - $176.56 $30 Million - $42 Million
237,912 New
237,912 $37.1 Million
Q2 2020

Aug 07, 2020
SELL
$126.3 - $176.56 $31.5 Million - $44 Million
-249,476 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$124.16 - $247.74 $31 Million - $61.8 Million
249,476 New
249,476 $36 Million
Q1 2020

May 08, 2020
SELL
$124.16 - $247.74 $31.7 Million - $63.3 Million
-255,315 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$74.57 - $217.92 $19 Million - $55.6 Million
255,315 New
255,315 $52.2 Million
Q4 2019

Feb 12, 2020
SELL
$74.57 - $217.92 $8.87 Million - $25.9 Million
-118,917 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$71.26 - $95.75 $8.47 Million - $11.4 Million
118,917 New
118,917 $9.55 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email